We study the causes of disease progression, with a specific focus on cancer, in order to identify which extrinsic and intrinsic factors can contribute to disease mutation occurrence in DNA, as well as to discover molecula
Research Interests: Role of the RET proto-oncogene in cancer.
Dr. Lois Mulligan was appointed as the Bracken Chair in Genetics and Molecular Medicine effective July 1, 2023 for a five-year term.
Translational aspects of Gastrointestinal cancer.
Research: Molecular hemostasis.
Clinical and Pathologic studies of gastrointestinal neoplasia.
Clinical Biochemist
Focus in GI and Gynecologic Pathology.
Identification and validation of novel therapeutic targets in breast cancer.
Webpage at the Sinclair Cancer Research Institute (SCRI)
Updated: 2023Dec21